Xiaoqing Cao , Yurou Kang , Ping Tai, Pei Zhang, Xin Lin, Fei Xu, Zhenlin Nie, Bangshun He
{"title":"肿瘤浸润淋巴细胞在胃癌预后中的作用:一项系统综述和荟萃分析。","authors":"Xiaoqing Cao , Yurou Kang , Ping Tai, Pei Zhang, Xin Lin, Fei Xu, Zhenlin Nie, Bangshun He","doi":"10.1016/j.clinre.2024.102510","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>To analyze the relationship between tumor-infiltrating lymphocytes (TILs) subtypes and infiltration locations and the prognosis of gastric cancer (GC) patients.</div></div><div><h3>Methods</h3><div>Eligible articles were obtained through systematic retrieval and rigorous screening, collecting study information and extracting hazard ratio (HR), 95 % confidence interval (CI) for pooled analyses of disease-free survival (DFS) and overall survival (OS).</div></div><div><h3>Results</h3><div>Higher CD4<sup>+</sup> TILs were correlated with favorable OS (HR=0.79, 95 %CI: 0.66–0.94, <em>P</em> = 0.009), the similar results were observed in tumor center and in infiltration margin. Higher CD8<sup>+</sup> TILs prolonged DFS (HR=0.69, 95 %CI: 0.51–0.95, <em>P</em> = 0.02) and OS (HR=0.96, 95 %CI: 0.94–0.99, <em>P</em> = 0.006); For OS, tumor center and infiltration margin groups showed positive results. Neither the overall analysis nor the subgroup analyses indicated that the level of FOXP3<sup>+</sup> TILs was associated with prognosis (DFS: HR=0.89, 95 %CI: 0.66–1.19, <em>P</em> = 0.42; OS: HR=0.98, 95 %CI: 0.85–1.13, <em>P</em> = 0.75). Pooled results revealed that higher CD3<sup>+</sup> TILs were correlated with favorable DFS (HR=0.69, 95 %CI: 0.56–0.84, <em>P</em> = 0.0003) but not OS (HR=1.00, 95 %CI: 0.99–1.01, <em>P</em> = 0.48).</div></div><div><h3>Conclusions</h3><div>High infiltrating CD3<sup>+</sup>, CD4<sup>+</sup>, CD8<sup>+</sup> T cells prolong survival, and FOXP3<sup>+</sup> subset is not related to prognosis in GC. For CD4<sup>+</sup> and CD8<sup>+</sup>, positive correlations between the infiltration level and OS were present in tumor center and infiltration margin groups.</div></div>","PeriodicalId":10424,"journal":{"name":"Clinics and research in hepatology and gastroenterology","volume":"49 1","pages":"Article 102510"},"PeriodicalIF":2.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis\",\"authors\":\"Xiaoqing Cao , Yurou Kang , Ping Tai, Pei Zhang, Xin Lin, Fei Xu, Zhenlin Nie, Bangshun He\",\"doi\":\"10.1016/j.clinre.2024.102510\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>To analyze the relationship between tumor-infiltrating lymphocytes (TILs) subtypes and infiltration locations and the prognosis of gastric cancer (GC) patients.</div></div><div><h3>Methods</h3><div>Eligible articles were obtained through systematic retrieval and rigorous screening, collecting study information and extracting hazard ratio (HR), 95 % confidence interval (CI) for pooled analyses of disease-free survival (DFS) and overall survival (OS).</div></div><div><h3>Results</h3><div>Higher CD4<sup>+</sup> TILs were correlated with favorable OS (HR=0.79, 95 %CI: 0.66–0.94, <em>P</em> = 0.009), the similar results were observed in tumor center and in infiltration margin. Higher CD8<sup>+</sup> TILs prolonged DFS (HR=0.69, 95 %CI: 0.51–0.95, <em>P</em> = 0.02) and OS (HR=0.96, 95 %CI: 0.94–0.99, <em>P</em> = 0.006); For OS, tumor center and infiltration margin groups showed positive results. Neither the overall analysis nor the subgroup analyses indicated that the level of FOXP3<sup>+</sup> TILs was associated with prognosis (DFS: HR=0.89, 95 %CI: 0.66–1.19, <em>P</em> = 0.42; OS: HR=0.98, 95 %CI: 0.85–1.13, <em>P</em> = 0.75). Pooled results revealed that higher CD3<sup>+</sup> TILs were correlated with favorable DFS (HR=0.69, 95 %CI: 0.56–0.84, <em>P</em> = 0.0003) but not OS (HR=1.00, 95 %CI: 0.99–1.01, <em>P</em> = 0.48).</div></div><div><h3>Conclusions</h3><div>High infiltrating CD3<sup>+</sup>, CD4<sup>+</sup>, CD8<sup>+</sup> T cells prolong survival, and FOXP3<sup>+</sup> subset is not related to prognosis in GC. For CD4<sup>+</sup> and CD8<sup>+</sup>, positive correlations between the infiltration level and OS were present in tumor center and infiltration margin groups.</div></div>\",\"PeriodicalId\":10424,\"journal\":{\"name\":\"Clinics and research in hepatology and gastroenterology\",\"volume\":\"49 1\",\"pages\":\"Article 102510\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinics and research in hepatology and gastroenterology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2210740124002316\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinics and research in hepatology and gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2210740124002316","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis
Background
To analyze the relationship between tumor-infiltrating lymphocytes (TILs) subtypes and infiltration locations and the prognosis of gastric cancer (GC) patients.
Methods
Eligible articles were obtained through systematic retrieval and rigorous screening, collecting study information and extracting hazard ratio (HR), 95 % confidence interval (CI) for pooled analyses of disease-free survival (DFS) and overall survival (OS).
Results
Higher CD4+ TILs were correlated with favorable OS (HR=0.79, 95 %CI: 0.66–0.94, P = 0.009), the similar results were observed in tumor center and in infiltration margin. Higher CD8+ TILs prolonged DFS (HR=0.69, 95 %CI: 0.51–0.95, P = 0.02) and OS (HR=0.96, 95 %CI: 0.94–0.99, P = 0.006); For OS, tumor center and infiltration margin groups showed positive results. Neither the overall analysis nor the subgroup analyses indicated that the level of FOXP3+ TILs was associated with prognosis (DFS: HR=0.89, 95 %CI: 0.66–1.19, P = 0.42; OS: HR=0.98, 95 %CI: 0.85–1.13, P = 0.75). Pooled results revealed that higher CD3+ TILs were correlated with favorable DFS (HR=0.69, 95 %CI: 0.56–0.84, P = 0.0003) but not OS (HR=1.00, 95 %CI: 0.99–1.01, P = 0.48).
Conclusions
High infiltrating CD3+, CD4+, CD8+ T cells prolong survival, and FOXP3+ subset is not related to prognosis in GC. For CD4+ and CD8+, positive correlations between the infiltration level and OS were present in tumor center and infiltration margin groups.
期刊介绍:
Clinics and Research in Hepatology and Gastroenterology publishes high-quality original research papers in the field of hepatology and gastroenterology. The editors put the accent on rapid communication of new research and clinical developments and so called "hot topic" issues. Following a clear Editorial line, besides original articles and case reports, each issue features editorials, commentaries and reviews. The journal encourages research and discussion between all those involved in the specialty on an international level. All articles are peer reviewed by international experts, the articles in press are online and indexed in the international databases (Current Contents, Pubmed, Scopus, Science Direct).
Clinics and Research in Hepatology and Gastroenterology is a subscription journal (with optional open access), which allows you to publish your research without any cost to you (unless you proactively chose the open access option). Your article will be available to all researchers around the globe whose institution has a subscription to the journal.